Per Stirling Capital Management’s Amgen AMGN Stock Holding History

Per Stirling Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Sell	681 -6	-0.9%	-$2.05K	0.02%	306
2026 Q1	$242K	Buy	687 +13	+2%	+$4.63K	0.03%	283
2025 Q4	$221K	Buy	+674	New	+$214K	0.02%	284
2024 Q4	–	Sell	-1,180	Closed	-$380K	–	257
2024 Q3	$380K	Buy	1,180 +33	+3%	+$10.8K	0.05%	206
2024 Q2	$358K	Sell	1,147 -24	-2%	-$7.05K	0.06%	188
2024 Q1	$333K	Buy	1,171 +24	+2%	+$7.02K	0.06%	181
2023 Q4	$330K	Buy	1,147 +140	+14%	+$38.1K	0.06%	165
2023 Q3	$271K	Sell	1,007 -14	-1%	-$3.49K	0.06%	170
2023 Q2	$227K	Buy	1,021 +61	+6%	+$14.2K	0.05%	180
2023 Q1	$232K	Hold	960	–	–	0.05%	168
2022 Q4	$252K	Buy	+960	New	+$257K	0.05%	179

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Per Stirling Capital Management's AMGN Position: Q2 2026 in Review

Per Stirling Capital Management reduced its Amgen (AMGN) stake by 0.87% in Q2 2026, selling an estimated $2.05K and leaving 681 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #306.

Per Stirling Capital Management first reported a position in AMGN in Q4 2022 and has held it in 11 quarters since. The position peaked at $380K in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Per Stirling Capital Management held 681 shares of Amgen worth $247K as of Q2 2026.
Per Stirling Capital Management sold 6 Amgen shares in Q2 2026, an estimated $2.05K.
Amgen made up 0.02% of Per Stirling Capital Management's portfolio in Q2 2026, its #306 holding.
Per Stirling Capital Management first reported a position in Amgen in Q4 2022 and has held it in 11 quarters since.
Per Stirling Capital Management's Amgen position peaked at $380K in Q3 2024.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Per Stirling Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.